Activated platelets promote increased monocyte expression of CXCR5 through prostaglandin E2-related mechanisms and enhance the anti-inflammatory effects of CXCL13

Atherosclerosis

Volumn 234, Issue 2, 2014, Pages 352-359

  Halvorsen, Bente ^a,d   Smedbakken, Linda M ^a,d   Michelsen, Annika E ^a,d   Skjelland, Mona ^a   Bjerkeli, Vigdis ^a,d   Sagen, Ellen Lund ^a,d   Taskén, Kjetil ^b,c,d   Bendz, Bjørn ^a   Gullestad, Lars ^a,d   Holm, Sverre ^a   Biessen, Erik A ^e   Aukrust, Pål ^a,d  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY OF OSLO   (Norway)

^e MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Atherothrombosis; Chemokines; Inflammation; Monocytes; Platelets

Indexed keywords

3 (4 METHYLPHENYLSULFONYL) 2 PROPENENITRILE; BETA ADRENERGIC RECEPTOR; BUTAPROST; CHEMOKINE RECEPTOR CXCR5; CXCL13 CHEMOKINE; FLUPROSTENOL; ISOPRENALINE; MESSENGER RNA; PROSTAGLANDIN E2; RECOMBINANT CXCL13 CHEMOKINE; RECOMBINANT CYTOKINE; THROMBIN; TOLL LIKE RECEPTOR AGONIST; UNCLASSIFIED DRUG; CCL5 PROTEIN, HUMAN; CXCL13 PROTEIN, HUMAN; CXCR5 PROTEIN, HUMAN; RANTES;

ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; ATHEROSCLEROTIC PLAQUE; CAROTID ATHEROSCLEROSIS; CAROTID ENDARTERECTOMY; CONTROLLED STUDY; CYTOKINE RELEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MEDIATOR; MONOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBUS; ATHEROSCLEROSIS; BLOOD; CELL CULTURE; GENETICS; HEART INFARCTION; IMMUNOLOGY; INFLAMMATION; METABOLISM; PATHOLOGY; RUPTURE;

ATHEROSCLEROSIS; BLOOD PLATELETS; CELLS, CULTURED; CHEMOKINE CCL5; CHEMOKINE CXCL13; DINOPROSTONE; HUMANS; INFLAMMATION; MONOCYTES; MYOCARDIAL INFARCTION; PLAQUE, ATHEROSCLEROTIC; PLATELET ACTIVATION; RECEPTORS, CXCR5; RUPTURE, SPONTANEOUS; SIGNAL TRANSDUCTION; THROMBIN;

EID: 84900871412     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2014.03.021     Document Type: Article

References (20)

1. Libby P., Ridker P.M., Hansson G.K. Progress and challenges in translating the biology of atherosclerosis. Nature 2011, 473:317-325.
2. Weber C., Noels H. Atherosclerosis: current pathogenesis and therapeutic options. Nat Med 2011, 17:1410-1422.
3. Zernecke A., Shagdarsuren E., Weber C. Chemokines in atherosclerosis: an update. Arterioscler Thromb Vasc Biol 2008, 28:1897-1908.
4. Aukrust P., Halvorsen B., Yndestad A., et al. Chemokines and cardiovascular risk. Arterioscler Thromb Vasc Biol 2008, 28:1909-1919.
5. Damås J.K., Smith C., Øie E., et al. Enhanced expression of the homeostatic chemokines CCL19 and CCL21 in clinical and experimental atherosclerosis: possible pathogenic role in plaque destabilization. Arterioscler Thromb Vasc Biol 2007, 27:614-620.
6. Luchtefeld M., Grothusen C., Gagalick A., et al. Chemokine receptor 7 knockoutattenuates atherosclerotic plaque development. Circulation 2010, 122:1621-1628.
7. -/- mice. JExp Med 2009, 206:233-248.
8. Smedbakken L.M., Halvorsen B., Daissormont I., et al. Increased levels of the homeostatic chemokine CXCL13 in human atherosclerosis -potential role in plaque stabilization. Atherosclerosis 2012, 224:266-273.
9. Coppinger J.A., Cagney G., Toomey S., et al. Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions. Blood 2004, 103:2096-2104.
10. Müller F., Rollag H., Gaudernack G., Frøland S.S. Impaired invitro survival of monocytes from patients with HIV infection. Clin Exp Immunol 1990, 81:25-30.
11. Otterdal K., Smith C., Øie E., et al. Platelet-derived LIGHT induces inflammatory responses in endothelial cells and monocytes. Blood 2006, 108:928-935.
12. Breland U.M., Michelsen A.E., Skjelland M., et al. Raised MCP-4 levels in symptomatic carotid atherosclerosis: an inflammatory link between platelet and monocyte activation. Cardiovasc Res 2010, 86:265-273.
13. Sugimoto Y., Narumiya S. Prostaglandin E receptors. JBiol Chem 2007, 282:11613-11617.
14. 2. Thromb Haemost 2004, 92:1358-1367.
15. Aslanian A.M., Charo I.F. Targeted disruption of the scavenger receptor and chemokine CXCL16 accelerates atherosclerosis. Circulation 2006, 114:583-590.
16. Braunersreuther V., Zernecke A., Arnaud C., et al. CCR5 but not CCR1 deficiency reduces development of diet-induced atherosclerosis in mice. Arterioscler Thromb Vasc Biol 2007, 27:373-379.
17. Zernecke A., Bot I., Djalali-Talab Y., et al. Protective role of CXC receptor 4/CXC ligand 12 unveils the importance of neutrophils in atherosclerosis. Circ Res 2008, 102:209-217.
18. Damås J.K., Wæhre T., Yndestad A., et al. Stromal cell-derived factor-1α in unstable angina - potential anti-inflammatory and matrix stabilizing effects. Circulation 2002, 106:36-42.
19. + monocyte subset and monocyte-platelet interactions in patients with ST-elevation myocardial infarction. JThromb Haemost 2012, 10:1231-1241.
20. Serre K., Bénézech C., Desanti G., et al. Helios is associated with CD4 T cells differentiating to T helper 2 and follicular helper T cells invivo independent of Foxp3 expression. PloS One 2011, 6:e20731.